# Euphrasia Eye Drops in Preterm Infants With First Signs of Congestion of Nasolacrimal Duct

> **NCT04122300** · PHASE3 · COMPLETED · sponsor: **University of Bern** · enrollment: 84 (actual)

## Conditions studied

- Congenita Nasolacrimal Duct Obstruction
- Preterm Neonates
- Ocular Discharge

## Interventions

- **DRUG:** Euphrasia Officinalis Preparation
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04122300
- **Lead sponsor:** University of Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05-22
- **Primary completion:** 2016-12-12
- **Final completion:** 2016-12-16
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2019-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04122300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04122300, "Euphrasia Eye Drops in Preterm Infants With First Signs of Congestion of Nasolacrimal Duct". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT04122300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*